Advertisement

Topics

Companies Related to "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum" [Most Relevant Company Matches] - Page: 5 RSS

13:14 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum" found in our extensive corporate database of over 50,000 company records.

Showing "Phase Study AZD6244 Combination With Capecitabine Radiotheraphy Locally" Companies 101–125 of 1,600+

Probably Relevant

&intoconnection

&intoconnection performed a study on what it means for people to be strongly or weakly connected. Due to the international nature of the study, it is not only possible to measure connection by country, but it is also possible to compare connection between countries. The 14 countries studied were China, Japan, the U.S., Russia, Germany, Great Britain, France, Spain, South Africa, Argentina, Isr...


Tragara Pharmaceuticals

Tragara Pharmaceuticals, Inc. is a privately-held pharmaceutical company based in San Diego, Calif. The company is focused on the clinical and commercial development of proprietary medicines for the treatment of cancer and inflammation. Tragara's lead therapeutic program, Capoxigem® (apricoxib, TG01), is currently in Phase II clinical development in lung and pancreatic cancers and has completed...

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and colony management, research study applications, safety testing, custom antibody production or fully-compliant Good Laboratory Practices, BIOCON implements our client’s research initiative with dedicat...


Cmed Clinical Services

Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical monitoring, data management, biostatistics, medical and regulatory affairs, and medical writing. Through the coupling of our own proprietary e-clinical technology, Timaeus, with our study delivery teams, Cmed Clinical Serv...

Health Mart Systems, Inc.

Health Mart is America's fastest-growing independent pharmacy franchise with more than 3,200 locally owned community pharmacies in all 50 states. Health Mart pharmacists provide personalized care and take the time to help patients understand their prescription-drug coverage, how to safely manage multiple medications, and how to take advantage of lower-cost...

Boston Biostatistics Incorporated

Boston Biostatistics, Inc. is a Phase II-IV independent contract research organization providing clinical trials support services to drug development and medical product companies. BBI provides clinical monitoring, medical monitoring, data management, data analysis, report writing, study planning, regulatory affairs and related services.BBI has been operating profitably since its inception in 1983...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...

Long Island Clinical Research Associates

Long Island Clinical Research Associates, LLP (LICRA) is an affiliate organization of Nassau Gastroenterology Associates, P.C. We are a privately owned clinical research center in Great Neck, New York. Conveniently located to New York City and its suburbs, LICRA services a multi-racial and multi-ethnic population of more than 12 million, allowing recruitment from a diverse group of clinical study ...

Intercern

Intercern is a pan-European clinical trials network supported by teams of dedicated clinical research professionals. We offer consultancy, design, implementation and running of phase I-IV clinical studies. Intercern can demonstrate radical improvements over the traditional expectations of study timelines and patient recruitment targets.Intercern represents a network of over 200 premier clinical tr...

Arno Therapeutics, Inc.

Arno Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. In addition to AR-67, Arno's lead clinical compound is AR-12, a potentially first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces autophagy and the endoplasmi...

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...

QST Consultations, Ltd.

QST Consultations, Ltd. was founded in 1974 to support pharmaceutical and medical device companies in their clinical research endeavors. QST specializes in clinical study design, data management, biostatistical services, medical writing, and electronic FDA submissions. QST has been instrumental in successful Phase I-III and device trials integral to...

Cold Genesys Inc.

Cold Genesys, Inc. is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. In 2010, Cold Genesys acquired exclusive worldwide rights to develop CG0070 from BioSante Pharmaceuticals. CG0070 is currently under investigation in a Phase II, single-arm, open-label, pivotal study (BOND II) for patient...

Genitope

Genitope Corporation is a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. Immunotherapy products are designed to utilize the immune system to combat diseases such as cancer. Our lead product candidate, MyVax® Personalized Immunotherapy (previously referred to as GTOP-99) is currently in a pivotal Phase 3 trial for the treatment o...

CardioVascular BioTherapeutics, Inc.

CVBT is a biopharmaceutical company developing drug candidates with FGF-1 as its active pharmaceutical ingredient (API) for diseases characterized by inadequate blood flow to a tissue or organ. The company has FDA-authorization for a Phase II trial to treat severe Coronary Heart Disease (CVBT-141H) and a Phase I trial to treat Peripheral Arterial Disease (CVBT-141C). A Phase III trial to treat der...

HCA

HCA is one of the nation’s leading providers of healthcare services, comprised of locally managed facilities that include approximately 165 hospitals and 116 freestanding surgery centers in 20 states and London.

B. McLaughlin Associates, Inc.

BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits.

TOPICA Pharmaceuticals, Inc.

TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, or fungal infections of the nail. The company is focused on conducting the Phase 2b/3 SOLUTION Study, a robust dose finding and proof of efficacy trial with luliconazole in onychomycosis with...

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is ag...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

Chiltern International Limited

Established in 1982, Chiltern has amassed extensive experience in running trials from Phase I to Phase IV and across a broad therapeutic range. And with offices throughout Europe and in North America, Chiltern can provide an extensive range of services for both the international and national management of your studies.Chiltern has a proven ability to bring all the key elements required for the suc...

ideallianceinc

The Idealliance was originally formed as the North Carolina Emerging Technology Alliance (NCETA) in 1998. This organization of academic, business and government leaders was created in response to recommendations put forth in a study commissioned by the Greater Winston-Salem Chamber of Commerce. This study, entitled Forsyth County’s Blueprint for Technology Development, was part of a community-wi...

Averion Inc.

Averion Inc. (Averion) is a full-service clinical research organization (CRO) that is committed to advancing medical products through clinical development, regulatory approval, and beyond. Averion provides medical device, biotechnology, and pharmaceutical partners with proactive guidance, critical thinking and dedicated client support for their product development programs. Averion is trusted in i...

CRDE Sp. j.

CRDE was founded in 2002 as niche CRO focused on managing clinical trials phase I-IV in oncology, metabolic disorders, cardiovascular disorders and pediatrics. Such therapeutic areas are very demanding and require specialized knowledge to understand study design and procedures, endpoints, safety issues and patient populationsOur Medical and Clinical Operations staff have proven experience and appl...

Immunomedics, Inc.

Immunomedics (the “Company”) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Immunomedics’ advanced proprietary technologies allow the Company to create humanized antibodies that can be used either alone in unlabeled ...


More From BioPortfolio on "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks